IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Bristol-Myers Squibb Co

CUSIP: 110122AN8 | TRACE | 33 institutional holders

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q2 2023

Victory Capital Management Inc14,996,000
0.0% of portfolio›$25.6M
UBS Group AG34,000
0.0% of portfolio›$57.7K
Proequities, Inc.0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Victory Capital Management Inc
14,996,000$25.6M0.0%CoreMediumSan Antonio, TX2023-07-27
UBS Group AG
34,000$57.7K0.0%CoreMediumZurich, Switzerland2023-08-11
Proequities, Inc.
0$00.0%GrowthVery LowBirmingham, AL2023-08-10